DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Wednesday reported a loss of $8 million in its first quarter.
On a per-share basis, the Devon, Pennsylvania-based company said it had a loss of 20 cents.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.
The company's shares closed at $4.16. A year ago, they were trading at $4.45.
The Associated Press